Quizartinib is an FLT3 inhibitor. It’s used for AML that comes back or doesn’t respond to treatment, especially when there are FLT3-ITD mutations. It stops FLT3 signaling, which is a big deal in cancer cell growth.
You can get it in two doses—17.7 mg and 26.5 mg—they’re both tablets with a coating. You usually start with 53 mg a day after a little warm-up time. It comes in bottles with 28 tablets in each.
And there’s no info on the price in the description.
